Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Chem Soc
2006 Dec 13;12849:15701-13. doi: 10.1021/ja064324k.
Show Gene links
Show Anatomy links
Binding of muscimol-conjugated quantum dots to GABAC receptors.
Gussin HA
,
Tomlinson ID
,
Little DM
,
Warnement MR
,
Qian H
,
Rosenthal SJ
,
Pepperberg DR
.
???displayArticle.abstract???
Functionalization of highly fluorescent CdSe/ZnS core-shell nanocrystals (quantum dots, qdots) is an emerging technology for labeling cell surface proteins. We have synthesized a conjugate consisting of approximately 150-200 muscimols (a GABA receptor agonist) covalently joined to the qdot via a poly(ethylene glycol) (PEG) linker (approximately 78 ethylene glycol units) and investigated the binding of this muscimol-PEG-qdot conjugate to homomeric rho1 GABAC receptors expressed in Xenopus oocytes. GABAC receptors mediate inhibitory synaptic signaling at multiple locations in the central nervous system (CNS). Binding of the conjugate was analyzed quantitatively by determining the fluorescence intensity of the oocyte surface membrane in relation to that of the surrounding incubation medium. Upon 5- to 10-min incubation with muscimol-PEG-qdots (34 nM in qdot concentration), GABAC-expressing oocytes exhibited a fluorescent halo at the surface membrane that significantly exceeded the fluorescence of the incubation medium. This halo was absent following muscimol-PEG-qdot treatment of oocytes lacking GABAC receptors. Incubation of the oocyte with free muscimol (100 microM-5 mM), PEG-muscimol (500 microM), or GABA (100 microM - 5 mM) substantially reduced or eliminated the fluorescence halo produced by muscimol-PEG-qdots, and the removal of GABA or free muscimol led to a recovery of muscimol-PEG-qdot binding. Unconjugated qdots and PEG-qdots that lacked conjugated muscimol neither exhibited significant binding activity nor diminished the subsequent binding of muscimol-PEG-qdots. The results indicate that muscimol joined to qdots via a long-chain PEG linker exhibits specific binding activity at the ligand-binding pocket of expressed GABAC receptors, despite the presence of both the long PEG linker and the sterically bulky qdot.
???displayArticle.pubmedLink???
17147380
???displayArticle.pmcLink???PMC2553244 ???displayArticle.link???J Am Chem Soc ???displayArticle.grants???[+]
Akerman,
Nanocrystal targeting in vivo.
2002, Pubmed
Akerman,
Nanocrystal targeting in vivo.
2002,
Pubmed
Alivisatos,
The use of nanocrystals in biological detection.
2004,
Pubmed
Bäumle,
Highly fluorescent streptavidin-coated CdSe nanoparticles: preparation in water, characterization, and micropatterning.
2004,
Pubmed
Bentzen,
Surface modification to reduce nonspecific binding of quantum dots in live cell assays.
2005,
Pubmed
Bruchez,
Semiconductor nanocrystals as fluorescent biological labels.
1998,
Pubmed
Chan,
Quantum dot bioconjugates for ultrasensitive nonisotopic detection.
1998,
Pubmed
Chang,
Channel opening locks agonist onto the GABAC receptor.
1999,
Pubmed
Chebib,
GABAC receptor ion channels.
2004,
Pubmed
Dahan,
Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.
2003,
Pubmed
Doughty,
Benextramine-neuropeptide Y receptor interactions: contribution of the benzylic moieties to [3H]neuropeptide Y displacement activity.
1993,
Pubmed
Dubertret,
In vivo imaging of quantum dots encapsulated in phospholipid micelles.
2002,
Pubmed
,
Xenbase
Enz,
Immunocytochemical localization of the GABAc receptor rho subunits in the mammalian retina.
1996,
Pubmed
Euler,
Different contributions of GABAA and GABAC receptors to rod and cone bipolar cells in a rat retinal slice preparation.
1998,
Pubmed
Gao,
In vivo cancer targeting and imaging with semiconductor quantum dots.
2004,
Pubmed
Gibbs,
Opposing roles for GABAA and GABAC receptors in short-term memory formation in young chicks.
2005,
Pubmed
Goldman,
Multiplexed toxin analysis using four colors of quantum dot fluororeagents.
2004,
Pubmed
Goldman,
Avidin: a natural bridge for quantum dot-antibody conjugates.
2002,
Pubmed
Hoshino,
Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body.
2004,
Pubmed
Howarth,
Targeting quantum dots to surface proteins in living cells with biotin ligase.
2005,
Pubmed
Jovin,
Quantum dots finally come of age.
2003,
Pubmed
Kim,
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping.
2004,
Pubmed
Lester,
Experiments with photoisomerizable molecules at nicotinic acetylcholine receptors in cells and membrane patches from rat muscle.
1986,
Pubmed
Lidke,
Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
2004,
Pubmed
Lukasiewicz,
Different combinations of GABAA and GABAC receptors confer distinct temporal properties to retinal synaptic responses.
1998,
Pubmed
Lukasiewicz,
Synaptic mechanisms that shape visual signaling at the inner retina.
2005,
Pubmed
Mason,
Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates.
2005,
Pubmed
Mason,
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
2005,
Pubmed
Meissner,
Lateral mobility and specific binding to GABA(A) receptors on hippocampal neurons monitored by fluorescence correlation spectroscopy.
2003,
Pubmed
Milligan,
Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons.
2004,
Pubmed
Minet,
Heat stress induced redistribution of fluorescent quantum dots in breast tumor cells.
2004,
Pubmed
Nehilla,
Neurotransmitter analog tethered to a silicon platform for neuro-BioMEMS applications.
2004,
Pubmed
Pan,
Interactions between rho and gamma2 subunits of the GABA receptor.
2005,
Pubmed
,
Xenbase
Pathak,
Quantum dot applications to neuroscience: new tools for probing neurons and glia.
2006,
Pubmed
Qian,
Molecular and pharmacological properties of GABA-rho subunits from white perch retina.
1998,
Pubmed
,
Xenbase
Qian,
Pharmacology of novel GABA receptors found on rod horizontal cells of the white perch retina.
1994,
Pubmed
Rosenthal,
Targeting cell surface receptors with ligand-conjugated nanocrystals.
2002,
Pubmed
,
Xenbase
Sedelnikova,
Mapping the rho1 GABA(C) receptor agonist binding pocket. Constructing a complete model.
2005,
Pubmed
Seitz,
Processive movement of single kinesins on crowded microtubules visualized using quantum dots.
2006,
Pubmed
Shen,
Multireceptor GABAergic regulation of synaptic communication in amphibian retina.
2001,
Pubmed
Tomlinson,
Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots.
2005,
Pubmed
Tomlinson,
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells.
2005,
Pubmed
Vu,
Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment.
2005,
Pubmed
,
Xenbase
Vu,
Peptide-conjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth.
2005,
Pubmed
Wang,
GABA(A) receptor binding and localization in the tiger salamander retina.
2000,
Pubmed
Watson,
Lighting up cells with quantum dots.
2003,
Pubmed
Wu,
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots.
2003,
Pubmed
Yang,
Simultaneous detection of Escherichia coli O157:H7 and Salmonella Typhimurium using quantum dots as fluorescence labels.
2006,
Pubmed
Young,
Qdot nanocrystal conjugates conjugated to bombesin or ANG II label the cognate G protein-coupled receptor in living cells.
2006,
Pubmed
Zhang,
Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block.
1995,
Pubmed
,
Xenbase
